Is Praxis Precision Stock a Good Investment?
Praxis Precision Investment Advice | PRAX |
- Examine Praxis Precision's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Praxis Precision's leadership team and their track record. Good management can help Praxis Precision navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Praxis Precision's business and its evolving consumer preferences.
- Compare Praxis Precision's performance and market position to its competitors. Analyze how Praxis Precision is positioned in terms of product offerings, innovation, and market share.
- Check if Praxis Precision pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Praxis Precision's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Praxis Precision Medicines stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Praxis Precision Medicines is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Praxis Precision Stock
Researching Praxis Precision's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 100.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Praxis Precision Med has Price/Earnings To Growth (PEG) ratio of 0.03. The entity recorded a loss per share of 10.87. The firm had not issued any dividends in recent years. Praxis Precision had 1:15 split on the 29th of November 2023.
To determine if Praxis Precision is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Praxis Precision's research are outlined below:
| Praxis Precision Med generated a negative expected return over the last 90 days | |
| Praxis Precision Med has high historical volatility and very poor performance | |
| Praxis Precision Med has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 8.55 M. Net Loss for the year was (182.82 M) with loss before overhead, payroll, taxes, and interest of (143.86 M). | |
| Praxis Precision Medicines currently holds about 165.4 M in cash with (131.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7. | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Souza Marcio of 37500 shares of Praxis Precision subject to Rule 16b-3 |
Praxis Precision Quarterly Liabilities And Stockholders Equity |
|
Praxis Precision uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Praxis Precision Medicines. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Praxis Precision's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Praxis Precision's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Praxis Precision's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-11 | 2023-03-31 | -0.79 | -0.71 | 0.08 | 10 | ||
2023-02-07 | 2022-12-31 | -0.78 | -0.87 | -0.09 | 11 | ||
2023-11-07 | 2023-09-30 | -0.35 | -0.18 | 0.17 | 48 | ||
2023-08-09 | 2023-06-30 | -0.66 | -0.49 | 0.17 | 25 | ||
2022-05-09 | 2022-03-31 | -1.3 | -1.51 | -0.21 | 16 | ||
2021-08-16 | 2021-06-30 | -0.67 | -0.88 | -0.21 | 31 | ||
2022-02-28 | 2021-12-31 | -1.08 | -1.3 | -0.22 | 20 | ||
2021-03-17 | 2020-12-31 | -0.37 | -0.87 | -0.5 | 135 |
Know Praxis Precision's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Praxis Precision is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Praxis Precision Medicines backward and forwards among themselves. Praxis Precision's institutional investor refers to the entity that pools money to purchase Praxis Precision's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Adage Capital Partners Gp Llc | 2024-12-31 | 605 K | Assenagon Asset Management Sa | 2024-12-31 | 559.1 K | Point72 Asset Management, L.p. | 2024-12-31 | 521.3 K | Verition Fund Managegment, Llc | 2024-12-31 | 464.5 K | Geode Capital Management, Llc | 2024-12-31 | 406.7 K | Franklin Resources Inc | 2024-12-31 | 389.8 K | Cibc Global Asset Management Inc | 2024-12-31 | 366.8 K | Baker Bros Advisors Lp | 2024-12-31 | 331.5 K | Nuveen Asset Management, Llc | 2024-12-31 | 306.9 K | Cormorant Asset Management, Llc | 2024-12-31 | 1.7 M | Blackrock Inc | 2024-12-31 | 1.5 M |
Praxis Precision's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 770.03 M.Market Cap |
|
Praxis Precision's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.38) | (0.40) | |
| Return On Capital Employed | (0.45) | (0.47) | |
| Return On Assets | (0.38) | (0.40) | |
| Return On Equity | (0.41) | (0.43) |
Determining Praxis Precision's profitability involves analyzing its financial statements and using various financial metrics to determine if Praxis Precision is a good buy. For example, gross profit margin measures Praxis Precision's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Praxis Precision's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Praxis Precision's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Praxis Precision Medicines. Check Praxis Precision's Beneish M Score to see the likelihood of Praxis Precision's management manipulating its earnings.
Evaluate Praxis Precision's management efficiency
Praxis Precision Med has return on total asset (ROA) of (0.4382) % which means that it has lost $0.4382 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7098) %, meaning that it created substantial loss on money invested by shareholders. Praxis Precision's management efficiency ratios could be used to measure how well Praxis Precision manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.4 in 2025. Return On Capital Employed is likely to drop to -0.47 in 2025. At this time, Praxis Precision's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 108.3 M in 2025, whereas Other Current Assets are likely to drop slightly above 7 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 24.88 | 23.63 | |
| Tangible Book Value Per Share | 24.88 | 23.63 | |
| Enterprise Value Over EBITDA | (5.82) | (5.52) | |
| Price Book Value Ratio | 3.09 | 1.74 | |
| Enterprise Value Multiple | (5.82) | (5.52) | |
| Price Fair Value | 3.09 | 1.74 | |
| Enterprise Value | 1.2 B | 1.2 B |
Evaluating the management effectiveness of Praxis Precision allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Praxis Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta 2.774 |
Basic technical analysis of Praxis Stock
As of the 27th of March, Praxis Precision holds the Risk Adjusted Performance of (0.07), coefficient of variation of (1,091), and Variance of 47.49. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Praxis Precision, as well as the relationship between them.Praxis Precision's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Praxis Precision insiders, such as employees or executives, is commonly permitted as long as it does not rely on Praxis Precision's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Praxis Precision insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Praxis Precision's Outstanding Corporate Bonds
Praxis Precision issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Praxis Precision Med uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Praxis bonds can be classified according to their maturity, which is the date when Praxis Precision Medicines has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| PRAXAIR INC 355 Corp BondUS74005PBD50 | View | |
| US74005PBT03 Corp BondUS74005PBT03 | View | |
| PRAXAIR INC 32 Corp BondUS74005PBQ63 | View | |
| US74005PBS20 Corp BondUS74005PBS20 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Praxis Precision's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Praxis Precision's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 4.17 | |||
| Coefficient Of Variation | (1,091) | |||
| Standard Deviation | 6.89 | |||
| Variance | 47.49 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 51.59 | |||
| Value At Risk | (13.08) | |||
| Potential Upside | 5.7 | |||
| Skewness | (3.29) | |||
| Kurtosis | 17.04 |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 4.17 | |||
| Coefficient Of Variation | (1,091) | |||
| Standard Deviation | 6.89 | |||
| Variance | 47.49 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 51.59 | |||
| Value At Risk | (13.08) | |||
| Potential Upside | 5.7 | |||
| Skewness | (3.29) | |||
| Kurtosis | 17.04 |
Consider Praxis Precision's intraday indicators
Praxis Precision intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Praxis Precision stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Praxis Precision Corporate Filings
| 19th of March 2025 Other Reports | ViewVerify | |
8K | 28th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
F4 | 14th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Praxis Stock media impact
Far too much social signal, news, headlines, and media speculation about Praxis Precision that are available to investors today. That information is available publicly through Praxis media outlets and privately through word of mouth or via Praxis internal channels. However, regardless of the origin, that massive amount of Praxis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Praxis Precision news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Praxis Precision relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Praxis Precision's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Praxis Precision alpha.
Praxis Precision Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Praxis Precision can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Praxis Precision Maximum Pain Price Across June 20th 2025 Option Contracts
Praxis Precision's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Praxis Precision close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Praxis Precision's options.
Praxis Precision Corporate Management
| Dr B | CoFounder Officer | Profile | |
| Timothy Kelly | CFO Treasurer | Profile | |
| Nicole Sweeny | Chief Officer | Profile | |
| Kelly McCue | Chief Officer | Profile | |
| Alyssa Wyant | Chief Officer | Profile | |
| Megan Sniecinski | Chief Officer | Profile | |
| Lauren Mastrocola | VP Officer | Profile |
Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.